Abstract
The current study included estimation of Aldose reductase (AR) activity in serum of diabetic patients. The study included (47) samples of seram from diabetic patients serum (both types I and II), the patients age ranged from (9-80) years old, and (36) samples of seram from healthy people (control group) aged between (12-80) years old. The results showed significant elevation (P <0.05) in the AR activity in diabetic patients for both types compared with control group. The AR activity was (38.65 ±9.60) IU/ L in the serum of type II diabetes patients and (29.52 ± 5.75) IU/ L in patients with type I diabetes, compared to (11.01 ± 2.19) IU/ L in the serum of healthy people
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
